Met Life Investment Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 80,696 shares of IRWD stock, worth $284,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,696
Previous 80,696 -0.0%
Holding current value
$284,856
Previous $526,000 37.07%
% of portfolio
0.0%
Previous 0.0%

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$5.58 - $8.61 $50,923 - $78,574
9,126 Added 12.75%
80,696 $526,000
Q1 2024

May 14, 2024
BUY
$8.32 - $15.45 $595,462 - $1.11 Million
71,570 New
71,570 $623,000
Q3 2023

May 09, 2024
BUY
$8.25 - $11.35 $11,896 - $16,366
1,442 Added 2.06%
71,570 $689,000
Q2 2023

Apr 29, 2024
BUY
$10.1 - $11.6 $722,857 - $830,212
71,570 New
71,570 $761,000
Q2 2023

Aug 10, 2023
BUY
$10.1 - $11.6 $14,564 - $16,727
1,442 Added 2.06%
71,570 $761,000
Q1 2023

May 09, 2024
BUY
$10.37 - $12.56 $727,227 - $880,807
70,128 New
70,128 $738 Million
Q3 2022

May 10, 2024
SELL
$10.14 - $12.38 $60,890 - $74,341
-6,005 Reduced 7.89%
70,128 $726,000
Q3 2022

Mar 22, 2023
SELL
$10.14 - $12.38 $60,890 - $74,341
-6,005 Reduced 7.89%
70,128 $726,000
Q3 2022

Nov 14, 2022
SELL
$10.14 - $12.38 $60,890 - $74,341
-6,005 Reduced 7.89%
70,128 $727,000
Q2 2022

May 10, 2024
SELL
$11.05 - $12.72 $34,431 - $39,635
-3,116 Reduced 3.93%
76,133 $877,000
Q2 2022

Jun 20, 2023
BUY
$11.05 - $12.72 $66,355 - $76,383
6,005 Added 8.56%
76,133 $877,000
Q2 2022

Mar 22, 2023
SELL
$11.05 - $12.72 $34,431 - $39,635
-3,116 Reduced 3.93%
76,133 $877,000
Q2 2022

Aug 11, 2022
SELL
$11.05 - $12.72 $34,431 - $39,635
-3,116 Reduced 3.93%
76,133 $878,000
Q1 2022

May 10, 2024
BUY
$10.61 - $12.88 $840,831 - $1.02 Million
79,249 New
79,249 $996,000
Q1 2022

Jun 20, 2023
BUY
$10.61 - $12.88 $96,773 - $117,478
9,121 Added 13.01%
79,249 $996,000
Q1 2022

Mar 22, 2023
BUY
$10.61 - $12.88 $300,135 - $364,349
28,288 Added 55.51%
79,249 $996,000
Q1 2022

May 12, 2022
BUY
$10.61 - $12.88 $300,135 - $364,349
28,288 Added 55.51%
79,249 $997,000
Q4 2021

Jun 21, 2023
SELL
$10.86 - $13.95 $208,153 - $267,379
-19,167 Reduced 27.33%
50,961 $594,000
Q3 2021

May 17, 2024
SELL
$11.92 - $13.92 $119,593 - $139,659
-10,033 Reduced 16.45%
50,961 $665,000
Q3 2021

Jun 21, 2023
SELL
$11.92 - $13.92 $228,470 - $266,804
-19,167 Reduced 27.33%
50,961 $665,000
Q3 2021

Mar 22, 2023
SELL
$11.92 - $13.92 $119,593 - $139,659
-10,033 Reduced 16.45%
50,961 $665,000
Q3 2021

Nov 15, 2021
SELL
$11.92 - $13.92 $119,593 - $139,659
-10,033 Reduced 16.45%
50,961 $666,000
Q2 2021

Jun 21, 2023
SELL
$10.16 - $13.11 $92,801 - $119,746
-9,134 Reduced 13.02%
60,994 $784,000
Q1 2021

May 17, 2024
SELL
$9.04 - $11.86 $95,607 - $125,431
-10,576 Reduced 14.78%
60,994 $681,000
Q1 2021

Jun 26, 2023
SELL
$9.04 - $11.86 $82,571 - $108,329
-9,134 Reduced 13.02%
60,994 $682 Million
Q1 2021

Mar 22, 2023
BUY
$9.04 - $11.86 $2,675 - $3,510
296 Added 0.49%
60,994 $681,000
Q1 2021

May 14, 2021
BUY
$9.04 - $11.86 $2,675 - $3,510
296 Added 0.49%
60,994 $682,000
Q4 2020

May 24, 2024
SELL
$9.05 - $12.2 $83,848 - $113,033
-9,265 Reduced 13.24%
60,698 $691,000
Q4 2020

Jun 22, 2023
SELL
$9.05 - $12.2 $85,341 - $115,046
-9,430 Reduced 13.45%
60,698 $691,000
Q4 2020

Mar 22, 2023
SELL
$9.05 - $12.2 $83,848 - $113,033
-9,265 Reduced 13.24%
60,698 $691,000
Q4 2020

Feb 16, 2021
SELL
$9.05 - $12.2 $83,848 - $113,033
-9,265 Reduced 13.24%
60,698 $691,000
Q3 2020

Jun 26, 2023
SELL
$8.99 - $10.74 $1,483 - $1,772
-165 Reduced 0.24%
69,963 $628,000
Q2 2020

May 24, 2024
SELL
$9.14 - $11.97 $14,687 - $19,235
-1,607 Reduced 2.25%
69,963 $722 Million
Q2 2020

Jun 26, 2023
SELL
$9.14 - $11.97 $1,508 - $1,975
-165 Reduced 0.24%
69,963 $722,000
Q1 2020

Jul 12, 2023
SELL
$8.58 - $14.01 $1,415 - $2,311
-165 Reduced 0.24%
69,963 $705,000
Q4 2019

Jul 12, 2023
SELL
$8.22 - $14.0 $1,356 - $2,310
-165 Reduced 0.24%
69,963 $931,000
Q3 2019

Jul 12, 2023
SELL
$8.59 - $10.96 $1,417 - $1,808
-165 Reduced 0.24%
69,963 $600,000
Q3 2019

Mar 22, 2023
BUY
$8.59 - $10.96 $53,953 - $68,839
6,281 Added 9.86%
69,963 $600,000
Q3 2019

Nov 14, 2019
BUY
$8.59 - $10.96 $53,953 - $68,839
6,281 Added 9.86%
69,963 $601,000
Q2 2019

Jul 12, 2023
SELL
$9.8 - $12.89 $1,617 - $2,126
-165 Reduced 0.24%
69,963 $765,000
Q1 2019

Jul 13, 2023
SELL
$8.27 - $12.73 $53,308 - $82,057
-6,446 Reduced 9.19%
63,682 $721,000
Q4 2018

Jul 13, 2023
SELL
$7.8 - $16.13 $50,278 - $103,973
-6,446 Reduced 9.19%
63,682 $552,000
Q4 2018

Mar 22, 2023
SELL
$7.8 - $16.13 $268,101 - $554,420
-34,372 Reduced 35.05%
63,682 $552,000
Q4 2018

Feb 14, 2019
SELL
$7.8 - $16.13 $268,101 - $554,420
-34,372 Reduced 35.05%
63,682 $660,000
Q3 2018

Jul 13, 2023
SELL
$14.31 - $17.65 $92,242 - $113,771
-6,446 Reduced 9.19%
63,682 $984,000
Q3 2018

Mar 22, 2023
BUY
$14.31 - $17.65 $399,621 - $492,893
27,926 Added 39.82%
98,054 $1.52 Million
Q3 2018

Nov 14, 2018
BUY
$14.31 - $17.65 $491,863 - $606,665
34,372 Added 53.97%
98,054 $1.81 Million
Q4 2017

Feb 15, 2018
BUY
$12.16 - $14.58 $774,373 - $928,483
63,682
63,682 $955,000

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email